An Act to promote transparency in prescription drug prices
Summary
By Ms. Barber of Somerville, a petition (accompanied by bill, House, No. 3223) of Christine P. Barber and others relative to further regulating prescription drug price increases. Public Health.
Bill status
passed both
4 of 5 stages cleared
Introduction
Jan 2017
Committee Review
Jul 2017
House Passage
Mar 2018
Senate Passage
May 2018
Governor
Introduced Jan 23, 2017
Last action Jun 13, 2018
Floor votes
How they voted
This bill passed the Senate. No roll call record of that vote is available.
Full legislative history
Actions timeline
Total actions
12
Key actions
5
Committee
2
May 29, 2018
Upper · Passed
Senate concurred
upper
Apr 26, 2018
Upper · Passed
Senate concurred
upper
Mar 1, 2018
Lower · Passed
House concurred
lower
Jul 10, 2017
Upper · Passed
Senate concurred
upper
Jul 7, 2017
Committee
Discharged to the committee on Health Care Financing
lower
Jan 23, 2017
Upper · Passed
Senate concurred
upper
Jan 23, 2017
Committee
Referred to the committee on Public Health
lower
1 primary · 12 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Christine Barber
DDemocratic
Co
Carmine Gentile
DDemocratic
Co
Carolyn C. Dykema
DDemocratic
Co
CW
Chris Walsh
DDemocratic
Co
Daniel R. Cullinane
DDemocratic
Co
Dylan Fernandes
DDemocratic
Co
Jason Lewis
DDemocratic
Co
Ken Gordon
DDemocratic
Co
Marjorie Decker
DDemocratic
Co
Mary Keefe
DDemocratic
Co
Mike Connolly
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about H 3223
Scope: MA
Hi! I can help you understand H 3223. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline